Arctic Bioscience AS (OSL:ABS)

Norway · Delayed Price · Currency is NOK

2.560

-0.440 (-14.67%)

Aug 4, 2026, 2:27 PM CET

Arctic Bioscience AS Financials Overview

Financials in millions NOK. Fiscal year is January - December.

Millions NOK. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	42.62	42.62	44.4	33.76	34.47	21.52
Revenue Growth	-7.13%	-4.01%	31.55%	-2.07%	60.21%	4.48%
Gross Profit	2.09	13.57	12.81	9.78	11.84	5.16
Operating Income	-33.45	-33.45	-47.79	-48.59	-37.39	-40.58
Net Income	-41.03	-41.03	-47.93	-45.51	-34.02	-42.58
Earnings Per Share	-1.32	-1.32	-1.89	-1.79	-1.39	-1.75
EPS Growth	-	-	-	-	-	-

Revenue by Segment

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
B2C	4.85	4.85	4.95	4.28	3.49
B2B	35.25	35.25	38.53	29.47	30.78
Total	40.1	40.1	43.48	33.75	34.27

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	0	0	0	79.6	144.15	227.36
Total Debt	61.48	61.48	20.24	2.05	0	0
Net Cash (Debt)	-61.48	-61.48	-20.24	77.55	144.15	227.36
Net Cash Growth	-	-	-	-46.20%	-36.60%	5385.57%
Net Cash Per Share	-1.98	-1.98	-0.80	3.05	5.89	9.34

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-22.65	-22.65	-43.36	-30.37	-25.4	-39.49
Capital Expenditures	-22.75	-22.75	-50.81	-34.7	-58.57	-36.5
Free Cash Flow	-45.4	-45.4	-94.17	-65.07	-83.96	-76
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	4.90%	31.84%	28.84%	28.97%	34.36%	23.98%
Operating Margin	-78.47%	-78.47%	-107.63%	-143.93%	-108.47%	-188.60%
Pretax Margin	-96.25%	-96.25%	-107.95%	-134.84%	-98.71%	-197.90%
Profit Margin	-96.25%	-96.25%	-107.95%	-134.83%	-98.71%	-197.90%
FCF Margin	-106.52%	-106.52%	-212.07%	-192.78%	-243.58%	-353.22%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 5, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PS Ratio	1.62	2.07	1.05	7.89	8.34	20.10